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Abstract
Background: Hypnosis treatment in general practice is a rather new concept. This pilot study was
performed to evaluate the effect of a standardized hypnosis treatment used in general practice for
patients with chronic widespread pain (CWP).
Methods: The study was designed as a randomized control group-controlled study. Sixteen
patients were randomized into a treatment group or a control group, each constituting eight
patients. Seven patients in the treatment group completed the schedule. After the control period,
five of the patients in the control group also received treatment, making a total of 12 patients having
completed the treatment sessions. The intervention group went through a standardized hypnosis
treatment with ten consecutive therapeutic sessions once a week, each lasting for about 30
minutes, focusing on ego-strengthening, relaxation, releasing muscular tension and increasing self-
efficacy. A questionnaire was developed in order to calibrate the symptoms before and after the
10 weeks period, and the results were interpolated into a scale from 0 to 100, increasing numbers
representing increasing suffering. Data were analyzed by means of T-tests.
Results: The treatment group improved from their symptoms, (change from 62.5 to 55.4), while
the control group deteriorated, (change from 37.2 to 45.1), (p = 0,045). The 12 patients who
completed the treatment showed a mean improvement from 51.5 to 41.6. (p = 0,046). One year
later the corresponding result was 41.3, indicating a persisting improvement.
Conclusion: The study indicates that hypnosis treatment may have a positive effect on pain and
quality of life for patients with chronic muscular pain. Considering the limited number of patients,
more studies should be conducted to confirm the results.
Trial Registration: The study was registered in ClinicalTrials.gov and released 27.08.07 Reg nr
NCT00521807 Approval Number: 05032001.
Background
Chronic widespread pain (CWP) is defined by the classifi-
cation criteria of The American College of Rheumatology
from 1990 as pain during at least four of the days of the
week lasting for at least three months, localized both over
and below the waist, and on both the left and right side of
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at least 11 out of 18 defined positive trigger points, the
condition will be defined as fibromyalgia (FM).
Pain in the muscular-skeleton system is common both in
Norway and in the northern hemisphere. In one Norwe-
gian study, 22% out of 2664 randomly selected women
reported chronic widespread muscular pain, while 25%
reported chronic localized muscular pain [2]. Another
study of Norwegian women aged 20–50 years found a
prevalence of FM and CWP on 10.5% and 25%, respec-
tively [3].
It appears that muscular pain is representing a continuous
spectrum from just a little pain to chronic debilitating
pain. One study concludes: "There is little evidence that
fibromyalgia or chronic, widespread pain comprises a dis-
tinct entity. It is more likely that these criteria select per-
sons at one end of a continuum of pain, from humdrum
nuisance to chronic, disabling disease" [4]. Both physical
and psychological factors are believed to be involved in
the development of chronic muscular pain, and it is sup-
posed that it exist individual differences in sensitivity and
tolerance for various stimuli [5,6].
The treatment offered at present to patients with CWP
ranges from physiotherapy, analgetic drugs, advices about
varied physical activity both at work and in leisure time,
psychomotoric physiotherapy, consulting therapy and
antidepressant medications. Over the years the patients
may have slight variations in their degree of suffering,
although the symptoms usually stay fairly unchanged
over time [7]. The condition seems to have both biologi-
cal and psychological causes. Hence a treatment like hyp-
nosis, aiming both at improving mind-body control and
psychological mastering, seems theoretically rational.
One experimental study including forty-five patients with
fibromyalgia finds that hypnosis followed by analgesia
suggestions has a greater effect on the intensity of pain
and on the sensory dimension of pain than hypnosis fol-
lowed by relaxation suggestions; and that the effect of
hypnosis followed by relaxation suggestions is not greater
than relaxation [8]. This indicates that hypnotic treatment
might influence physiologic responses through mental
processes.
In another study the researchers measured regional cere-
bral blood flow with positron emission tomography in
patients with fibromyalgia, during hypnotically-induced
analgesia and resting wakefulness [9]. The patients experi-
enced less pain during hypnosis than at rest, and the
blood-flow pattern of the brain was notably changed, sup-
porting notions of a multifactorial nature of hypnotic
analgesia, with an interplay between cortical and subcor-
tical brain dynamics.
Therapeutic use of hypnosis is not common in the north-
ern hemisphere, and has only to a small extent been tested
in relation to chronic muscular pain. A review of 13 con-
trolled prospective trials of hypnosis for the treatment of
chronic pain indicate that hypnosis interventions consist-
ently produce significant decreases in pain associated with
a variety of chronic-pain problems [10]. However, the
authors comment that there is a lack of standardization of
the hypnotic interventions examined in clinical trials, and
that the number of patients enrolled in the studies has
tended to be low and lacking long-term follow-up.
One Norwegian study that used guided imagery found
reduction of fibromyalgic pain during the study period
[11]. In a German trial it was not possible to measure an
effect of hypnosis on chronic pain [12]. In a Dutch con-
trolled study hypnotherapy was found to reduce pain
experience in patients with refractory fibromyalgia, but
this was not reflected in an improvement of the total
myalgic score measured by a dolorimeter [13]. The
authors conclude that further studies should be con-
ducted with patients having a shorter history of disease.
The present study was conducted to develop and docu-
ment the effect of a standardized hypnosis treatment used
in general practice for patients with CWP.
Methods
The study is a randomized, controlled study, and was con-
ducted during 2001 – 2003. Eighteen patients having had
CWP for at least three months and at most five years were
recruited from the main authors' own general practice, or
from colleagues working in the same area. Patients having
primarily other organic diseases or serious psychiatric dis-
orders were excluded. Two of the patients did not attend
the first session, and the remaining 16 patients, 12
women and four men, aged 23–54 years, were rand-
omized into an intervention group and a control group. In
the 10 week intervention period both groups were offered
similar treatments according to normal routines in gen-
eral practice, with the addition of hypnosis treatment in
the intervention group. The treatments included different
combinations of medications such as analgesics and anti-
depressants, and physiotherapy or chiropractic therapy.
One patient in the intervention group did not continue
through the whole treatment schedule, but is included in
the material in accordance with the statistical principle of
intention to treat [14]. Hence there were seven patients
completing the treatment during the first phase (Figure 1).
After the 10 week period, all the eight patients in the con-
trol group were offered the hypnosis treatment, and as fivePage 2 of 7
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treatment.
The intervention group went through a standardized hyp-
nosis treatment once a week for ten weeks. The treatment
was performed by the main author, being a general prac-
titioner with special interest and training in hypnosis.
Hypnosis is a treatment where the patient is inducted into
a slightly altered state of consciousness, still being alert
and awake, but more distanced from the outer world, and
more focused on his or her inner thoughts and emotions
[15]. Each therapeutic session lasted for about 30 min-
utes, focusing on ego-strengthening, relaxation, releasing
muscular tension and increasing the self-efficacy. Visuali-
zation techniques were used to improve self-evaluation
and to create a more positive body experience. The con-
Float diagram of participants in the studyigure 1
Float diagram of participants in the study.
Inclusion  10 weeks treatment / control Treatment after control
First analysis Second analysis
2 did not
attend 3 did not
18 patients  accept
included 8 controll
 
16 patients 1 did not 5 treatment
complete 12 got treatment
8 treatment all together
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Hypnosis in general practice – how is it done?Figure 2
Hypnosis in general practice – how is it done?
 
 
 
 
 
 
 
 
 
 
A normal doctor’s office is used. The patient is normally lying on a couch, or may be seated in a good chair. 
The therapist is seated on the side, and partly behind the patient. Normally the door is locked, the light 
dimmed and the telephone shut off. The patient is instructed about the routines of hypnosis, and specifically 
about the principle that the therapist is just giving suggestions, not commands. The patient is then asked to 
listen to the therapists’ voice, and let other noises or sensations just float around and fade away. The session 
after this will normally last about half an hour, consisting of an induction, a theme and a termination. The 
therapist talks slowly, evenly, often trying to follow the rhythm of the patient’s breath. In the induction, 
several techniques can be used to make the patient comfortable and relaxed, and focused on the therapist’s 
suggestions. In the thematic part, suggestions and visualizations are made in accordance to the goal of the 
therapy, e.g. relaxation, pain reduction etc. In the termination, the patient is prepared to wake up, and 
allowed enough time to absorb the experience and get ready for normal aware state of mind. Experienced 
therapists may improvise during the therapy, others often use prewritten scripts which can be devised 
individually, or collected from books or numerous internet sites. 
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vious one, in order to make the patient more comfortable
and able to relax during the treatment. The treatment was
based on a manual which was developed for the study,
prescribing every treatment session in detail, and followed
rigorously and in the same order for every patient. Every
hypnosis session was recorded on audio tape, which the
patient kept for use at home before the next session. More
details about hypnosis in general practice is given in Fig-
ure 2
The treatment performed in this study was, like most hyp-
nosis performed by professionals, based on permissive
suggestions in conformation with the patients consent. Of
the present two mainstreams of theoretical basis for hyp-
nosis, the more individualistic ideas of Milton H. Ericson
were introduced to all the patients suggesting that their
experience during hypnosis is unique and valid without
necessity for objective evaluation or scaling [15]. On the
other hand, the actual treatment was more in the line of
Ernest G. Hilgard's theories in the sense that a standard
treatment was given to all the participants, without indi-
vidual adjustments [15]. This is in accordance with our
aim to make a standardized tool but still respecting the
individualistic nature of the experience of hypnosis.
A questionnaire was developed as to measure the patients'
symptoms, consisting of 25 questions divided into five
main sections (Additional file 1). The first section con-
cerned pain at activity and rest, fatigue and concentration
problems, the second was dealing with activities of daily
life, like dressing, carrying groceries, walking and running.
The third section was one question concerning subjective
evaluation of quality of life in total. The fourth was an
estimate of how much the pain interfered with work, hob-
bies and social life, and the fifth was an estimate of feel-
ings of inadequacy, anxiety, loneliness and pessimism.
The questionnaire contained elements from WHOQOL-
BREF – a questionnaire concerning quality of life devel-
oped by WHO [16], from SHC – Subjective Health Com-
plaint inventory developed by Ursin et al [17], and from
Hopkins Symptom Checklist (SCL-5) [18].
The results were interpolated into a scale from 0 to 100,
increasing numbers representing increasing suffering
(Additional file 2).
All participants answered the questionnaire at the time of
inclusion, and again after 10 weeks. Those patients receiv-
ing treatment after the control period also answered the
same questionnaire once more after the treatment. In
addition, all the 12 patients who received treatment filled
in the same questionnaire one year later, including an
additional question on use of the audio-tapes from the
hypnosis sessions.
Data analysis (T-tests) was performed with SPSS version
12. The p-value was set to p ≤ 0.05. The study was
approved by the Norwegian Southern Regional Commit-
tee for Medical Research Ethics. All patients were given
written information about the study at the time of inclu-
sion, and their oral consent to participate was noted in
their journals.
The study was registered in ClinicalTrials.gov and released
27.08.07 Reg nr NCT00521807 Approval Number:
05032001. It was registered after it was completed, since
registration of clinical trials was not so prevalent at the
time it was carried out.
Results
The seven patients in the treatment group showed an aver-
age improvement in scores of -7.1 from 62.5 to 55.4,
whilst the eight patients in the control group had a deteri-
oration of 7.9 from 37.2 to 45.1. A T-test showed the dif-
ference between the groups to be statistically significant (p
= 0.045).
The five patients who received hypnosis treatment after
first having been part of the control group had an average
improvement of -12.43 from 35.97 to 23.54. The scores
for the individual patients are shown in Figure 3.
The total of 12 patients who completed the treatment
showed a mean improvement of -9.9 from 51.5 to 41.6. It
was done an estimate from a zero-hypothesis, since there
was no longer any control group to compare with. A one-
sample T-test on this material shows the improvement to
be statistically significant (p = 0.046).
All the 12 patients who received treatment answered the
questionnaire one year later. During treatment they
showed a mean improvement from 51.5 to 41.6, and after
a year the corresponding result was 41.3, indicating that
the improvement maintained at least for one year.
All the 12 patients reported that they used the audio tapes
they had received, or some other kind of auto-hypnosis, at
least once weekly, and three reported almost daily use. All
of the patients also reported that they most probably
would have accepted more hypnosis treatment, if availa-
ble.
Discussion
The study indicates that hypnosis treatment in general
practice for patients with CWP may have positive effects,
and that the effect persists over time.Page 4 of 7
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Symptom score before and after the treatment period in the treatment group and before and after the control period in the control group, (Blue and purpl  columns)Figure 3
Symptom score before and after the treatment period in the treatment group and before and after the con-
trol period in the control group, (Blue and purple columns). The results for the five patients in the control group who 
later received treatment is included (white column).
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required to make statistically significant results. Neverthe-
less, our analyses indicate statistically significant changes
during and after treatment. It seems that some of the
patients benefited strongly from the treatment, and these
are the major contributors to the positive results of the
study. This emphasizes the vulnerability of such a small
study, but it also raises the question as to whether the var-
iations is caused by different aetiology of the disease, or by
unequal hypnotic susceptibility.
In spite of being adequately randomized, the two groups
initially were very different according to their level of suf-
fering: the treatment group starting at 62.5 and the control
group at 37.2. This raises a question as to whether the part
of the study based on the comparison between groups is
reliable. The fact that the treatment group was worse off at
the start, also raises the question as to whether the results
are due to regression to the mean, indicating that there is
a tendency of the extremes to normalize [19]. This, how-
ever, does not seem to be the case for the five who received
treatment after first having been a part of the control-
group. Even though starting at a comparable low level of
suffering, they improved considerably during treatment.
This kind of study may be biased by the patients' wishes
to give good evaluations in order to please their therapist,
which will tend to influence the results in a positive direc-
tion. In the treatment period we tried to avoid the per-
sonal aspect by emphasizing to every paritisipant that the
results were anonymus also to the terapist, as the ques-
tionnaires were collected by the other author.
The questionnaire was developed specifically for this
study. It encompasses the parameters that the study was
designed to investigate, and is partly based on other, vali-
dated questionnaires, but it has not itself been scientifi-
cally validated. This dictates the need for caution in
interpretation of the results. However, this pilot study
indicates that further studies on hypnotic treatment for
muscular-skeletal diseases and pain might be rewarding.
Only two controlled studies were found on a PubMed
search using the words hypnosis, general practice and trial
or study [20,21]. Further studies clearly should include
more patients, and validated questionnaires should be
used.
Since the hypnosis treatment was not specifically designed
to relieve the symptoms of CWP, it would be interesting
to study the effect of a similar treatment for other kinds of
suffering, i.e. chronic rheumatic diseases, chronic pain
conditions, and psychical diseases like anxiety and depres-
sion.
The effect of the treatment will depend to some extent on
the experience of the therapist, and also on the relevance
of the suggestions and visualizations that are given. In this
respect the treatment can still be improved further, in
order to maximize the effect.
Recording of each therapeutic session makes way for
rationalizing the treatment, for example producing all the
sessions as CD-recordings combined with less time and
effort-demanding counselling by the therapist. Most
patients reported, however, that the live treatment done
by the therapist was the most effective. Use of recordings
versus live sessions should therefore be investigated in fur-
ther detail.
Provided with recordings of the treatment sessions, it is
also probable that the treatment could be copied by other
general practitioners, who would then be able to perform
the treatment after some specific directed training.
Conclusion
The study indicates that hypnosis treatment may have a
positive effect on pain and quality of life for patients with
chronic muscular pain The effect seems to persist for at
least one year. Considering the limited number of
patients, more studies should be conducted to confirm
the results.
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